Vous êtes ici

Home › Inscriptions › Sciences Biologiques › Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
AGN
Associated Securities: 
Algernon Pharmaceuticals Inc. 27APRIL2023 Rights
Indice CSE: 
Devise: 

Vous êtes ici

Accueil

Algernon Pharmaceuticals Inc. (AGN)

SEDAR Information

Formulaire de recherche

Information d'entreprise

Addresse
Suite 1500 - 1055 West Georgia Street
Vancouver, BC V6E4N7
Canada
Téléphone
604-398-4175
Courriel
info@algernonpharmaceuticals.com
URL
https://algernonpharmaceuticals.com
Date d’inscription à la cote
Lundi, février 1, 2016
Agent de transfert
TSX Trust Company
Vérificateur
Smythe LLP

Capitalisation

Capitalisation: 
21640762
Réservé à l'émission: 
13662036

Communiqués de presse

24/04/2024

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024

11/04/2024

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

Bulletins

21/04/2023

2023-0422 - Expiration - Algernon Pharmaceuticals Inc. - Rights (AGN.RT)

le 21 avril/April 2023

Algernon Pharmaceuticals Inc. Rights listed on March 28, 2023 will expire on April 27, 2023.

Settlement Terms: All trades April 25 and 26 will be for cash next day settlement. Trades on April 27 will be for cash same day.

The rights will be halted at noon and delisted at market close April 27, 2023.

___________________________

Dépôts CSE

Algernon - Mar 2024 Form 7 - Monthly Progress Report

Algernon Pharmaceuticals Inc. Material Change

Algernon Pharmaceuticals Inc. Form 10

Algernon Pharmaceuticals Inc. Form 6

Algernon Pharmaceuticals - Form 10 Notice of Proposed Significant Transaction